ms FRANCES VISCO

Funding for the DOD Breast Cancer Research Program of $150 million for FY09 Enactment of the S.579/H.R.1157, the Breast Cancer and Environmental Research Act

Funding for the DoD peer-reviewed Breast Cancer Research Program; Enactment of S579/HR1157 The Breast Cancer and Environmental Research Act

DOD Breast Cancer Research Program - FY09 Appropriations S.579/H.R.1157, Breast Cancer and Environmental Research Act - enactment

Funding for the DOD Breast Cancer Research Program of $150 million for FY09 Enactment of H.R.1157/S.579, the Breast Cancer and Environmental Research Act Guaranteed Access to Quality Health Care for All Preservation of the Breast and Cervical Cancer Treatment Program

Department of Defense Breast Cancer Research Program -- FY09 Appropriations S.579/H.R.1157 Breast Cancer and Environmental Research Act -- enactment Guaranteed Access to Quality Care for All -- general health issues, no specific legislation Breast and Cervical Cancer Treatment Program

Funding for the DoD peer-reviewed Breast Cancer Research Program; Enactment of S579/HR1157 The Breast Cancer and Environmental Research Act; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program

Funding for the DOD Breast Cancer Research Program of $150 million for FY09 Enactment of H.R.1157/S.579, the Breast Cancer and Environmental Research Act Guaranteed Access to Quality Health Care for All Preservation of the Breast and Cervical Cancer Treatment Program

DOD Breast Cancer Research Program - FY09 Appropriations S.579/H.R.1157 Breast Cancer and Environmental Research Act -- enactment

DOD Breast Cancer Research Program - FY09 Appropriations S.579/H.R.1157, Breast Cancer and Environmental Research Act - enactment Guaranteed Access to Quality Health Care for All -- general health care issues, no specific legislation Breast and Cervical Cancer Treatment Program

Funding for the DOD Breast Cancer Research Program of $150 million for FY09 Enactment of the S.579/H.R.1157, the Breast Cancer and Environmental Research Act

DOD Breast Cancer Research Program - FY09 Appropriations S.579/H.R.1157, Breast Cancer and Environmental Research Act - enactment Guaranteed Access to Quality Health Care for All -- general health care issues, no specific legislation Breast and Cervical Cancer Treatment Program

Department of Defense Breast Cancer Research Program -- FY09 Appropriations S.579/H.R.1157 Breast Cancer and Environmental Research Act -- enactment Guaranteed Access to Quality Care for All -- general health issues, no specific legislation Breast and Cervical Cancer Treatment Program

Funding for the DOD Breast Cancer Research Program of $150 million for FY09 Enactment of H.R.1157/S.579, the Breast Cancer and Environmental Research Act Guaranteed Access to Quality Health Care for All Preservation of the Breast and Cervical Cancer Treatment Program

DOD Breast Cancer Research Program - FY09 Appropriations S.579/H.R.1157 Breast Cancer and Environmental Research Act -- enactment

Funding for the DOD Breast Cancer Research Program of $150 million for FY09 Enactment of H.R.1157/S.579, the Breast Cancer and Environmental Research Act Guaranteed Access to Quality Health Care for All Preservation of the Breast and Cervical Cancer Treatment Program

Funding for the DoD peer-reviewed Breast Cancer Research Program; Enactment of S579/HR1157 The Breast Cancer and Environmental Research Act; Guaranteed Access to Quality Care for All; Breast and Cervical Cancer Treatment Program

Funding for the DOD Breast Cancer Research Program of $150 million for FY09 Enactment of the S.579/H.R.1157, the Breast Cancer and Environmental Research Act

DOD Breast Cancer Research Program - FY09 Appropriations S.579/H.R.1157, Breast Cancer and Environmental Research Act - enactment

Funding for the DoD peer-reviewed Breast Cancer Research Program; Enactment of S579/HR1157 The Breast Cancer and Environmental Research Act

Funding for the DOD Breast Cancer Research Program of $150 million for FY09 Enactment of the S.579/H.R.1157, the Breast Cancer and Environmental Research Act

Department of Defense Peer-Reviewed Breast Cancer Research Program - Fiscal Year 2008 appropriations. S. 579/H.R. 1157, the Breast Cancer and Environmental Research Act - enactment.

DOD Breast Cancer Research Program - FY08 Appropriations S.579/H.R.1157, Breast Cancer and Environmental Research Act - enactment Guaranteed Access to Quality Health Care for All -- general health care issues, no specific legislation Breast and Cervical Cancer Treatment Program

DOD Breast Cancer Research Program - FY08 Appropriations S.579/H.R.1157, Breast Cancer and Environmental Research Act - enactment

Department of Defense Peer-Reviewed Breast Cancer Research Program - Fiscal Year 2008 appropriations. S. 579/H.R. 1157, the Breast Cancer and Environmental Research Act - enactment.

DOD Breast Cancer Research Program - FY08 Appropriations S.579/H.R.1157, Breast Cancer and Environmental Research Act - enactment

Department of Defense Peer-Reviewed Breast Cancer Research Program - Fiscal Year 2008 appropriations. S. 579/H.R. 1157, the Breast Cancer and Environmental Research Act - enactment.

Department of Defense Peer-Reviewed Breast Cancer Research Program - Fiscal Year 2008 appropriations. S. 579/H.R. 1157, the Breast Cancer and Environmental Research Act - enactment.

DOD Breast Cancer Research Program - FY08 Appropriations S.579/H.R.1157, Breast Cancer and Environmental Research Act - enactment Guaranteed Access to Quality Health Care for All -- general health care issues, no specific legislation Breast and Cervical Cancer Treatment Program

Funding for DOD Breast Cancer Reserach Program; Passsage of S.757/H.R.2231, Breast Cancer and Environmental Research Act Guaranteed Access to Quality Health Care For All -- general health care issues -- but no specific legislation

Funding for DOD Breast Cancer Research Program; Passage of S.757/H.R.2231, the Breast Cancer and Environmental Research Act; Guaranteed Access to Quality Care for all -- general health care issues -- no specific legislation

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1288/S. 1037, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 1910, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1288/S. 1037, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 1910, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1288/S. 1037, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 1910, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1288/S. 1037, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 1910, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1288/S. 1037, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 1910, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1624/S. 913, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 830/H.R. 1723, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 602/S. 318, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information. Patients’ Bill of Rights: Patients deserve a comprehensive and enforceable patients’ bill of rights, with a right to sue, that includes coverage for routine health care costs associated with clinical trials; access to the right providers; involvement in treatment decisions that are based on good science; confidentiality of their health information, and the right to receive accurate information about their health plans. NBCC urges Congress to enact H.R. 2563/S. 1052, the Bipartisan Patient Protection Act which reflects these important principles. Medical Privacy Regulations - sent comments to the Department of Health and Human Services.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1624/S. 913, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 830/H.R. 1723, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 602/S. 318, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information. Patients’ Bill of Rights: Patients deserve a comprehensive and enforceable patients’ bill of rights, with a right to sue, that includes coverage for routine health care costs associated with clinical trials; access to the right providers; involvement in treatment decisions that are based on good science; confidentiality of their health information, and the right to receive accurate information about their health plans. NBCC urges Congress to enact H.R. 2563/S. 1052, the Bipartisan Patient Protection Act which reflects these important principles. Medical Privacy Regulations - sent comments to the Department of Health and Human Services.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1624/S. 913, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 830/H.R. 1723, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 602/S. 318, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information. Patients’ Bill of Rights: Patients deserve a comprehensive and enforceable patients’ bill of rights, with a right to sue, that includes coverage for routine health care costs associated with clinical trials; access to the right providers; involvement in treatment decisions that are based on good science; confidentiality of their health information, and the right to receive accurate information about their health plans. NBCC urges Congress to enact H.R. 2563/S. 1052, the Bipartisan Patient Protection Act which reflects these important principles. Medical Privacy Regulations - sent comments to the Department of Health and Human Services.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1624/S. 913, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 830/H.R. 1723, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 602/S. 318, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information. Patients’ Bill of Rights: Patients deserve a comprehensive and enforceable patients’ bill of rights, with a right to sue, that includes coverage for routine health care costs associated with clinical trials; access to the right providers; involvement in treatment decisions that are based on good science; confidentiality of their health information, and the right to receive accurate information about their health plans. NBCC urges Congress to enact H.R. 2563/S. 1052, the Bipartisan Patient Protection Act which reflects these important principles. Medical Privacy Regulations - sent comments to the Department of Health and Human Services.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1624/S. 913, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 830/H.R. 1723, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 602/S. 318, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information. Patients’ Bill of Rights: Patients deserve a comprehensive and enforceable patients’ bill of rights, with a right to sue, that includes coverage for routine health care costs associated with clinical trials; access to the right providers; involvement in treatment decisions that are based on good science; confidentiality of their health information, and the right to receive accurate information about their health plans. NBCC urges Congress to enact H.R. 2563/S. 1052, the Bipartisan Patient Protection Act which reflects these important principles. Medical Privacy Regulations - sent comments to the Department of Health and Human Services.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1624/S. 913, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 830/H.R. 1723, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 602/S. 318, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information. Patients’ Bill of Rights: Patients deserve a comprehensive and enforceable patients’ bill of rights, with a right to sue, that includes coverage for routine health care costs associated with clinical trials; access to the right providers; involvement in treatment decisions that are based on good science; confidentiality of their health information, and the right to receive accurate information about their health plans. NBCC urges Congress to enact H.R. 2563/S. 1052, the Bipartisan Patient Protection Act which reflects these important principles. Medical Privacy Regulations - sent comments to the Department of Health and Human Services.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1624/S. 913, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 830/H.R. 1723, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 602/S. 318, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information. Patients’ Bill of Rights: Patients deserve a comprehensive and enforceable patients’ bill of rights, with a right to sue, that includes coverage for routine health care costs associated with clinical trials; access to the right providers; involvement in treatment decisions that are based on good science; confidentiality of their health information, and the right to receive accurate information about their health plans. NBCC urges Congress to enact H.R. 2563/S. 1052, the Bipartisan Patient Protection Act which reflects these important principles. Medical Privacy Regulations - sent comments to the Department of Health and Human Services.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. Urge enactment of H.R. 1624/S. 913, the Access to Cancer Therapies Act which would provide Medicare coverage of oral anti-cancer drugs. This legislation will build on current Medicare policy by extending coverage to all cancer drugs, whether oral or injectable, for Medicare beneficiaries under Part B. Breast Cancer and Environmental Research Act NBCC urges Congress to enact S. 830/H.R. 1723, the Breast Cancer and Environmental Research Act, which would make grants for multi-institutional, multi-disciplinary research centers to study the potential links between the environment and breast cancer. These centers would award grants based on a competitive, peer-reviewed process that involves consumer advocates. Genetic Nondiscrimination in Health Insurance and Employment Act: NBCC urges Congress to enact H.R. 602/S. 318, the Genetic Information Nondiscrimination in Health Insurance and Employment Act. This legislation, which has strong enforcement mechanisms that include a right to sue, would prohibit health insurers and employers from discriminating based on genetic information. Patients’ Bill of Rights: Patients deserve a comprehensive and enforceable patients’ bill of rights, with a right to sue, that includes coverage for routine health care costs associated with clinical trials; access to the right providers; involvement in treatment decisions that are based on good science; confidentiality of their health information, and the right to receive accurate information about their health plans. NBCC urges Congress to enact H.R. 2563/S. 1052, the Bipartisan Patient Protection Act which reflects these important principles. Medical Privacy Regulations - sent comments to the Department of Health and Human Services.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.